CDIO vs VRTX: Which Stock is Better?
Side-by-side comparison of Cardio Diagnostics Holdings Inc and Vertex Pharmaceuticals Inc in 2026
CDIO
Cardio Diagnostics Holdings Inc
$2.01
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | CDIO | VRTX | Winner |
|---|---|---|---|
| Market Cap | $5.80M | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | -0.2% | 0.1% | VRTX |
| Gross Margin | 100.0% | 53.7% | CDIO |
Analyze CDIO
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CDIO or VRTX a better investment?
Comparing CDIO and VRTX: Cardio Diagnostics Holdings Inc has a market cap of $5.80M while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CDIO and VRTX?
CDIO (Cardio Diagnostics Holdings Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CDIO or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CDIO or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.2% for CDIO.
Which company is more profitable: CDIO or VRTX?
Cardio Diagnostics Holdings Inc (CDIO) has higher gross margins at 100.0% compared to 53.7% for VRTX.
Which is the larger company: CDIO or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $5.80M for CDIO.
Should I buy CDIO or VRTX in 2026?
Both CDIO and VRTX have investment merit. CDIO trades at $2.01 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CDIO and VRTX stock?
Key differences: Market Cap ($5.80M vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (-0.2% vs 0.1%), Gross Margin (100.0% vs 53.7%).